Different types of allospecific CTL clones identified by their ability to recognize peptide loading‐defective target cells
- 1 November 1991
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 21 (11) , 2767-2774
- https://doi.org/10.1002/eji.1830211118
Abstract
Allospecific immune responses against the MHC of another individual are remarkably strong, due to a high number of responding T cell clones. Although it has been demonstrated that some allospecific cytotoxic T lymphocytes (CTL) recognize peptides presented by allogeneic MHC class I molecules, it has remained unclear whether MHC molecules can be recognized directly. We used the H‐2b‐derived murine lymphoma mutant RMA‐S, which has a defect affecting peptide loading of class I molecules, to test whether recognition by allospecific CTL always requires the presence of peptides. Three types of anti‐H‐2Kb CTL clones can be distinguished by their ability to lyse RMA‐S target cells. Type A CTL clones efficiently lyse these target cells, the lysis by type B CTL clones is inefficient, and type C clones fail to lyse RMA‐S. Up‐regulation of the levels of H‐2Kb density improved lysis by type B clones, but did not lead to lysis by type C clones. Some type A and B CTL clones apparently can recognize class I molecules devoid of peptides, while others are likely to recognize peptides which are not affected by the presentation defect of RMA‐S. We suggest that type C clones are specific for peptides which are not presented by the mutant cells. The results show that the majority of alloreactive CTL recognize peptide/MHC complexes, while some CTL behave as if they can recognize class I molecules in the absence of MHC‐bound peptides.Keywords
This publication has 28 references indexed in Scilit:
- Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC moleculesNature, 1991
- The CD45RA molecule is expressed in naive murine CTL precursors but absent in memory and effector CTLInternational Immunology, 1991
- The molecular basis of alloreactivityImmunology Today, 1990
- The α3 domain of major histocompatibility complex class I molecules plays a critical role in cytotoxic T lymphocyte stimulationEuropean Journal of Immunology, 1989
- Association of class I major histocompatibility heavy and light chains induced by viral peptidesNature, 1989
- EXPERIMENTAL STRATEGIES AND INTERPRETATIONS IN THE ANALYSIS OF CHANGES IN MHC GENE EXPRESSION DURING TUMOUR PROGRESSIONInternational Journal of Immunogenetics, 1986
- Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategyNature, 1986
- Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism.The Journal of Experimental Medicine, 1985
- Therapy with monoclonal antibodies by elimination of T-cell subsets in vivoNature, 1984
- High determinant density may explain the phenomenon of alloreactivityImmunology Today, 1984